04.29.26 -- The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

Join Life Science Leader Chief Editor Ben Comer on April 30th at 11am eastern for the Return of Radiopharmaceuticals: Overcoming Operational Challenges And New Opportunities virtual event. Panelists will discuss emerging technologies and radioisotopes, what new market opportunities exist, and what manufacturing and delivery challenges remain for radiopharmaceutical developers. Registration is free.

Recruiting for rare disease clinical trials is daunting, and making patients aware of clinical trials, involving them in trial design, and building trust are a few ways sponsors can boost recruitment.

A complex Phase 1 neuropathy study with overnight stays achieved full enrollment and retention through careful planning, strong participant engagement, and disciplined operational execution.

Examine the treatment landscape for rare diseases and the rapid evolution of gene therapy across three key dimensions: editing platforms, delivery modalities, and delivery vehicles.

Modular automation with MTP enables plants to adapt quickly and scale efficiently. See how standardized, plug-and-produce modules reduce complexity and accelerate time-to-market.

Explore how Simulated Moving Bed (SMB) technology can enhance API production while overcoming common misconceptions about chromatographic purification.

See how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.

Unlock more accurate clinical trial matching by using AI to interpret complex patient notes, reducing the manual screening burden and identifying eligible candidates with higher precision.